When was Oxford Finance founded?

Oxford Finance was founded in 2002.

Where is Oxford Finance's headquarters located?

Oxford Finance's headquarters is located in Alexandria (United States).

How many companies has Oxford Finance invested in?

Oxford Finance has invested in 116 companies, including Headspace & AliveCor.

Which companies has Oxford Finance invested in lately?

Sokin & Headspace are the latest investments by Oxford Finance.

What sectors does Oxford Finance focus on for investments?

Top sectors in Oxford Finance's portfolio are Life Sciences (84 investments) and HealthTech (13 investments).

How many exits has Oxford Finance been involved in?

Oxford Finance's portfolio has seen 23 IPOs and 41 acquisitions.

Oxford Finance - 2026 Investor Profile, Portfolio, Team & Investment Trends

Q: How big is Oxford Finance's investment team?

Oxford Finance has a team of 7.

Oxford Finance, established in 2002, is a private debt fund primarily based in Alexandria, United States. It specializes in financing Conventional Debt round of companies based in United States. Its portfolio includes 116 firms, spanning the Life Sciences, HealthTech sectors.

As of Oct 2026, Oxford Finance has witnessed 64 portfolio exits so far. Its most notable investments include companies like Headspace, AliveCor and CareDx.

Its latest investment was a $100M Conventional Debt round in Sokin on Jan 28, 2026.

Key Metrics

Founded Year

2002

Location

Alexandria, United States

Portfolio Companies

Headspace, AliveCor & 114 more

Sectors of Investment

Life Sciences, HealthTech & 13 more

Stages of Investment

Conventional Debt, Venture Debt & 4 more

Locations of Investment

United States, United Kingdom & 4 more

View Oxford Finance's full profile

Oxford Finance has a portfolio of 116 companies. Their most notable investments are in GenapSys and Amino.Their portfolio spans across United States, United Kingdom, Canada and 3 more locations. They have invested in Life Sciences, HealthTech, High Tech and 12 other sectors, across stages such as Conventional Debt, Venture Debt and 4 more. Here is the list of top investments by Oxford Finance:

1. Headspace

Provider of mental health support services via application and human care. The company delivers personalized support through meditation, mindfulness, coaching, and therapy. It offers resources for stress management, sleep improvement, and mental well-being. The company also provides services to businesses, health plans, and organizations.

Key facts about Headspace

Founded Year: 2010
Location: Santa Monica (United States)
Last Known Valuation: $*****
Stage: Acquired
Total Funding till date: $178M
Employee Count: 1,559 as on Jul 31, 2026
Investors: Allen & Company, Advance Venture Partners and 50 Others
Latest Funding Round: Venture Debt, Jul 26, 2023, $*****
Highlight: Acquired

2. AliveCor

Developer of remote cardiac monitoring solutions and related analysis software. The company provides devices for consumers and healthcare professionals to monitor heart conditions. It offers solutions for healthcare systems, biopharma companies, payers, and employers. The company's offerings include devices, analysis software, and data integration solutions.

Key facts about AliveCor

Founded Year: 2010
Location: Mountain View (United States)
Valuation: $*****
Stage: Series F
Total Funding till date: $114M
Employee Count: 68 as on Aug 31, 2025
Investors: Qualcomm Ventures, Square 1 Bank and 17 Others
Latest Funding Round: Series F, Aug 16, 2022, $*****
Highlight: Editors' Pick

3. CareDx

Developer of medical solutions for transplant patients. It has developed precision medicine solutions that offer products, testing services, and digital healthcare solutions along with the pre-and post-transplant patient journey. It provides AlloSure products for a kidney transplant. It is a non-invasive donor-derived cell-free DNA test for identifying kidney injury. It can determine active rejection, enabling better management of your kidney transplant patients. Other products include heart transplants, lab products, remotrac, and others.

Key facts about CareDx

Founded Year: 1998
Location: Brisbane (United States)
Annual Revenue: $100M - $500M as on Dec 31, 2025
Stage: Public
Total Funding till date: $138M
Employee Count: 862 as on Aug 31, 2026
Investors: Intel, Integral Capital Partners and 24 Others
Latest Funding Round: Conventional Debt, Mar 01, 2018, $*****
Highlight: Public

4. Senseonics

Provider of implantable systems for continuous glucose monitoring. It designs, develops and commercializes glucose monitoring systems to be used directly by people. Their continuous glucose monitoring (CGM) system is an implantable system that has been designed to continually measure glucose levels in people with diabetes for a period of up to 90 days. Their CGM system includes a Sensor, Transmitter, and Mobile Medical Application. The miniaturized Sensor is designed to be implanted into the subcutaneous space of the upper arm and requires no battery or wires for the Sensor to communicate with the Transmitter. It has a connected app which provides the patient with a report of their glucose level.

Key facts about Senseonics

Founded Year: 1996
Location: Germantown (United States)
Annual Revenue: $10M - $50M as on Dec 31, 2025
Stage: Public
Total Funding till date: $165M
Employee Count: 288 as on Aug 31, 2026
Investors: Greenspring Associates, Vensana Capital and 9 Others
Latest Funding Round: Post IPO, May 20, 2025, $*****
Highlight: Public

5. Pulmonx

Pulmonx is a developer of smart devices for treating pulmonary diseases. The company is focused on developing and marketing minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders. It is currently engaged in the design, development, and manufacture of products that will improve the effectiveness and benefits of endoscopic lung volume reduction (ELVR) for patients with severe emphysema. The company's Zephyr Endobronchial Valve (EBV) therapy involves placing small one-way valves in the lung to prevent air from entering the most diseased regions while allowing fluids and trapped air to escape. The company has a CE Mark for the Zephyr Endobronchial Valves and has submitted a CE mark application for the Chartis System.

Key facts about Pulmonx

Founded Year: 1998
Location: Redwood City (United States)
Annual Revenue: $50M - $100M as on Dec 31, 2025
Stage: Public
Total Funding till date: $281M
Employee Count: 266 as on Aug 31, 2026
Investors: HTIF, RTW Investments and 18 Others
Latest Funding Round: Series D, May 05, 2020, $*****
Highlight: Public

View the full list of portfolio companies

Oxford Finance has invested in 116 companies over the last 22 years, with an average of 5 new investments annually in the last 10 years. As of Jan 2026, it has made 1 investment in this year. Its most recent first time investment was in Sokin and most recent follow-on round was in Amino.

Here are Oxford Finance's Year-on-Year Investment Trends:

Year	No. of Investments
Year	1^st Round	Follow-on	Total
2026 (YTD)	1	0	1
2025	0	0	0
2024	0	0	0
2023	2	1	3
2022	5	1	6
2021	9	1	10
2020	7	1	8
2019	9	0	9
2018	8	0	8
2017	3	0	3

View all investments by Oxford Finance

Oxford Finance has made 79 investments in Conventional Debt stage with an average round size of $30.5M, 31 investments in Venture Debt stage with an average round size of $21.7M and 2 investments in Series B stage with an average round size of $17M.

Here are Oxford Finance's investments by stage:

Stage of entry	No. of Investments
Conventional Debt	79
Venture Debt	31
Series B	2
Series C	2
Series A	1
Others	1

Note: We have considered here, only first round of investments

View all investments by Oxford Finance

Oxford Finance has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Healthcare, Enterprise Applications and HealthTech. Notably, it has invested in 88 Tech companies, 85 Enterprise (B2B) companies, 28 Tech hardware companies and at least 24 companies focusing on Software.

Here are Oxford Finance's investments by sector:

Sector	No. of Investments
Life Sciences	84
High Tech	19
Healthcare	16
Enterprise Applications	13
HealthTech	13
Others	40

Note: We have considered here, only first round of investments

View all investments by Oxford Finance

Oxford Finance has made most investments in United States (108), followed by United Kingdom where it has made 3 investments.

Here are Oxford Finance's investments by geography:

Country	No. of Investments
United States	108
United Kingdom	3
Canada	2
Germany	1
Italy	1
Others	1

Note: We have considered here, only first round of investments

View all investments by Oxford Finance

Oxford Finance has made 1 investments in 2026 so far - Sokin.

Here are the most recent investments by Oxford Finance:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
Jan 28, 2026	Sokin	United Kingdom	Conventional Debt	8771	-
Jul 26, 2023	Headspace	United States	Venture Debt	6808	-
May 11, 2023	Amino	United States	Series D	9110	Transformation Capital
May 11, 2023	Amino	United States	Venture Debt	6318	-
Nov 16, 2022	Pearl Street Dental Partners	United States	Conventional Debt	8243	-

See more recent investments made by Oxford Finance

23 of Oxford Finance's portfolio companies have become public. Sonendo got listed on the New York Stock Exchange (NYSE), in Oct 2021 at marketcap of $315M and RxSight got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $424M.

Here are Oxford Finance's portfolio companies that went public:

Filter this list

Company	IPO Date	First Invested on	First Round of Investment	Round Size
Sonendo	Oct 29, 2021	Mar 24, 2014	Conventional Debt	4265
RxSight	Jul 30, 2021	Dec 02, 2020	Conventional Debt	3011
CVRx	Jun 30, 2021	Aug 09, 2016	Conventional Debt	5384
Telesis Bio	Jun 18, 2021	Sep 09, 2019	Series A	3183
Immunocore	Feb 05, 2021	Jan 12, 2021	Conventional Debt	4406

View more details about public companies in Oxford Finance's portfolio

41 companies from Oxford Finance's portfolio have been acquired. The most recent acquisition was Headspace in Sep 2026 by Sword.com for $*****.

Here are Oxford Finance's portfolio companies that got acquired most recently:

Filter this list

Company	Acquisition Date	First Invested on	First Round of Investment	Round Size
Headspace	Sep 16, 2026	Jul 26, 2023	Venture Debt	5136
Vital Connect	Aug 06, 2026	Nov 29, 2017	Conventional Debt	7403
Assertio	May 13, 2026	Jun 30, 2008	Conventional Debt	6317
Radius Health	Jan 12, 2026	May 25, 2011	Conventional Debt	1912
Amino	Jun 11, 2025	May 11, 2023	Venture Debt	9815

View all acquired companies in Oxford Finance's portfolio

Oxford Finance has a team of 7 members located in United States.

View team details of Oxford Finance

Over the past 22 years, 639 investors have co-invested in Oxford Finance's portfolio companies. This includes funds and angels.

Invested before Oxford Finance: HHS, Orbimed and 397 others have invested in rounds before Oxford Finance. There are 11 companies where HHS has invested before Oxford Finance and 8 companies where Orbimed has invested before Oxford Finance.
Top Co-investors of Oxford Finance: 26 investors entered a company along with Oxford Finance. These include investors like SVB (22 companies).
Invested after Oxford Finance: A total of 214 investors have invested in Oxford Finance's portfolio after their investments. Top Investors include Perceptive Advisors (6 companies) and Ally Bridge Group (5 companies).